Myocarditis

C Basso - New England Journal of Medicine, 2022 - Mass Medical Soc
Myocarditis | New England Journal of Medicine Skip to main content The New England Journal
of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical Medicine …

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …

TA McDonagh, M Metra, M Adamo… - European heart …, 2021 - academic.oup.com
The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …

Authors/Task Force Members:… - European journal of …, 2022 - Wiley Online Library
Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

P Garcia-Pavia, C Rapezzi, Y Adler, M Arad… - European heart …, 2021 - academic.oup.com
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …

[HTML][HTML] Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

C Tschöpe, E Ammirati, B Bozkurt… - Nature Reviews …, 2021 - nature.com
Inflammatory cardiomyopathy, characterized by inflammatory cell infiltration into the
myocardium and a high risk of deteriorating cardiac function, has a heterogeneous …

Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study

C Basso, O Leone, S Rizzo, M De Gaspari… - European heart …, 2020 - academic.oup.com
Abstract Aims Coronavirus disease 2019 (COVID-19) due to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) has been associated with cardiovascular features of …

Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management

B Siripanthong, S Nazarian, D Muser, R Deo… - Heart rhythm, 2020 - Elsevier
Human coronavirus-associated myocarditis is known, and a number of coronavirus disease
19 (COVID-19)–related myocarditis cases have been reported. The pathophysiology of …

Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D …

P Garcia‐Pavia, C Rapezzi, Y Adler… - European journal of …, 2021 - Wiley Online Library
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …

ST-segment elevation myocardial infarction

B Vogel, BE Claessen, SV Arnold, D Chan… - Nature reviews Disease …, 2019 - nature.com
ST-segment elevation myocardial infarction (STEMI) is the most acute manifestation of
coronary artery disease and is associated with great morbidity and mortality. A complete …

Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis

L Zhang, M Awadalla, SS Mahmood… - European heart …, 2020 - academic.oup.com
Aims Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI).
Sparse data exist on the use of cardiovascular magnetic resonance (CMR) in ICI-associated …